Molecular mechanisms generating and stabilizing terminal 22q13 deletions in 44 subjects with Phelan/McDermid syndrome.
In this study, we used deletions at 22q13, which represent a substantial source of human pathology (Phelan/McDermid syndrome), as a model for investigating the molecular mechanisms of terminal deletions that are currently poorly understood. We characterized at the molecular level the genomic rearran...
Saved in:
Similar Items
-
P672: The evolving genetic landscape of Phelan-McDermid syndrome and implications for diagnostics
by: Mary Hames, et al.
Published: (2025-01-01) -
P060: Metabolic approach for the development and validation of candidate treatments for Phelan-McDermid syndrome
by: Bridgette Moffitt, et al.
Published: (2025-01-01) -
Phenotype and psychometric characterization of Phelan-McDermid syndrome patients: pioneering towards personalized medicine
by: Julián Nevado, et al.
Published: (2025-03-01) -
Orofacial Lymphedema in Phelan–McDermid Syndrome: A Case of Hemifacial Involvement and a Scoping Review
by: Domenico De Falco, et al.
Published: (2025-02-01) -
An open-label study evaluating the safety and efficacy of AMO-01 for the treatment of seizures in Phelan-McDermid syndrome
by: Tess Levy, et al.
Published: (2025-04-01)